Timing of cardiac resynchronization therapy after optimal medical therapy in patients with heart failure: temporal trends, predictors and association with outcomes

20 May 2025 (09:00 - 09:10)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor Alessandro Villaschi

Humanitas University, Milan (Italy)

6 More presentations in this session

Presentation thumbnail

Discussant panel

Presentation thumbnail

Treatment uptake in the era of quadruple pharmacotherapy for heart failure with reduced ejection fraction: from prescriptions to patient adherence and persistence

Doctor F. Lindberg (Stockholm, SE)

Presentation thumbnail

Improvements in medical therapy and prognosis for patients with HFrEF following the 2021 ESC HF Guidelines: a nationwide registry study

Doctor K. Berge (Nordbyhagen, NO)

Presentation thumbnail

Contemporary patient characterization and implementation of medical therapy for heart failure across the ejection fraction spectrum: the OPTIPHARM-HF registry

Doctor R. Inciardi (Brescia, IT)

Presentation thumbnail

Cardiac resynchronization therapy in heart failure: a target trial emulation study

Doctor C. Basile (Stockholm, SE)

Access the full session

Session thumbnail

Latest registries and observational studies

The Event

Event poster

Heart Failure 2025

20 May 2025 09:00 CET

You may be interested in

Congress Presentation

Referral timing for cardiac resynchronization therapy: what registry data tell us about best practice

Congress Presentation

Cardiac resynchronization therapy: an enabler for GDMT optimization in HFrEF? Data from the Swedish Heart Failure and the Swedish Pacemaker and Implantable Cardioverter-Defibrillator Registries.

Congress Presentation

Individualized treatment responses to cardiac resynchronization therapy: a cluster analysis of the Swedish heart failure registry

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources